ArticleCancers2025

Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with Lenvatinib.

Takeshi Terashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.